PharmAla Launches Prescriber’s Portal for Medical Professionals Focused on MDMA Therapy
GlobeNewswire
TORONTO, May 03, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“*PharmAla*” or the “*Company*”) (CSE: MDMA)..
TORONTO, May 03, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“*PharmAla*” or the “*Company*”) (CSE: MDMA)..
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (“Lophos” or the “Company”) (CSE:MESC)..
Supply agreement marks Optimi’s first international shipment of research-grade active pharmaceutical ingredient (API) MDMA to..